Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Poland Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20063
20076
20081
20092
20101
20111
20131
20142
20153
20162
20181
20196
20202
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated3
Active, not recruiting2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Impax Laboratories, LLC4
Acorda Therapeutics3
GlaxoSmithKline3
Theravance Biopharma3
Boehringer Ingelheim2
Intec Pharma Ltd.2
Kyowa Kirin Co., Ltd.2
Solvay Pharmaceuticals2
UCB Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease38
Parkinsonian Disorders6
Brain Diseases4
Central Nervous System Diseases4
Dyskinesias4
Movement Disorders4
Nervous System Diseases4
Neurodegenerative Diseases4
Dizziness3
Hypotension3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.